Skip to content

Low-Level Diode Laser Therapy on the Acceleration of Osseointegration Around Delayed Dental Implant

The Efficacy of Low-Level Diode Laser Therapy on the Acceleration of Osseointegration and Mucosal Phenotype Around Delayed Dental Implant: A Randomized Controlled Clinical Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07536451
Enrollment
20
Registered
2026-04-17
Start date
2024-06-01
Completion date
2025-10-01
Last updated
2026-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implant

Brief summary

Good quality soft tissue determines the possibility not only to obtain full primary wound closure during the bone defect reconstruction, but also assures effective implant treatment and stability of peri-implant condition.Moreover, it is very important to assure the proper emergence profile of the implant supported restorations, which give the opportunity to achieve the highest aesthetic appearance. In the long-term, the correct width and thickness of the attached keratinized tissue is the key point to ensure the stable position of the mucosal line around the implant's neck. The promising outcomes of laser on soft and hard tissue have been demonstrating in a variety of studies. Therefore, the aim of this clinical study is to evaluate the efficacy of LLDLT on enhancing osseointegration and on the peri-implant mucosal tissue around delayed dental implants.

Interventions

OTHERDental implant + LLDL

implant placement in the posterior areas and implants will be placed with application of LLDL. Preparation of the alveolus for delayed dental implant placement will be done and LLDL application according to manufacturer instructions

OTHERDental implant

It includes ten patients seeking for implant placement at the posterior areas and those patients will be received their implants only without application of LLDL .

Sponsors

Hams Hamed Abdelrahman
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Patients are systemically medically free. * Ability to maintain good oral hygiene as evidenced in recall visits. * Sufficient mesiodistal and interocclusal space and have an intact buccal bone contours which does not require bone augmentation procedures. * Adequate bone quality. * Keratinized tissue ≥ 2mm. * Thickness of the gingiva ≥ 1 mm.

Exclusion criteria

* Presence of any systemic disease that could influence the outcome of the therapy. * Presence of any risk factor e.g.; smoker, pregnant, lactating patients or any disease affect bone healing. * Previous history of periodontal surgical treatment in quadrant selected for the study. * Restorations or caries in the area to be treated and non-vital tooth. * Adjacent teeth are tilted or rotated. * Patients taking medications known to cause affect bone quality. * Traumatic occlusion or Para-functional habits such as clenching or bruxism. * Participation in other clinical trials.

Design outcomes

Primary

MeasureTime frameDescription
Change in marginal bone loss2 weeks, 1month, 2 months, and 6 monthsTo assess the change in marginal bone loss, the linear distance from a fixed reference point-typically the implant shoulder or CEJ-to the highest level of bone-to-tooth/implant contact is measured.
Change in in implant stabilityImmediately after surgery, 2 months and 6months postoperative.Ostell device will be used to assess implant stability

Secondary

MeasureTime frameDescription
Change in bone density2 weeks, 1month, 2 months, and 6 monthsRadiographic examination of the patients will be done firstly pre-operative then at six months follow-up period post-operative by using CBCT device

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 18, 2026